Sellas Life Sciences earnings missed by $0.18, revenue was in line with estimates
- ByInvesting.com-
Investing.com - Sellas Life Sciences (NASDAQ: SLS) reported first quarter EPS of $-0.47, $0.18 worse than the analyst estimate of $-0.29. Revenue for the quarter came in at $0.00...